Filed: 5/14/2026ACC: 0001999371-26-010742
📋 What this filing means
GSK PLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $599.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$599.15M
Total AUM (reported)
51.03M
Total Shares
Allocation by class
COM$174.70M29.2%
NAMEN AKT$153.21M25.6%
SHS$132.28M22.1%
SPONSORED ADS$86.18M14.4%
COM NEW$52.78M8.8%
Portfolio Concentration
Top 3$364.57M60.8%
4–10$218.56M36.5%
11–25$16.02M2.7%
Top 3 weight
60.8%
Top 10 weight
97.3%
Voting Authority Distribution
Total shares with voting rights: 51.03M
Sole
Full voting authority
51.03M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
CRISPR THERAPEUTICS AG
SOLEShares3.22M
TypeSH
Market value$153.21M
25.57%
Sole
3.22M
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares18.25M
TypeSH
Market value$132.28M
22.08%
Sole
18.25M
Shared
0.00
None
0.00
BIONTECH SE
SOLEShares889.82K
TypeSH
Market value$79.09M
13.20%
Sole
889.82K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares8.55M
TypeSH
Market value$76.62M
12.79%
Sole
8.55M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares1.33M
TypeSH
Market value$44.43M
7.41%
Sole
1.33M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
SOLEShares1.51M
TypeSH
Market value$30.34M
5.06%
Sole
1.51M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares340.43K
TypeSH
Market value$22.44M
3.74%
Sole
340.43K
Shared
0.00
None
0.00
SPERO THERAPEUTICS INC
SOLEShares9.19M
TypeSH
Market value$21.51M
3.59%
Sole
9.19M
Shared
0.00
None
0.00
FULCRUM THERAPEUTICS INC
SOLEShares1.79M
TypeSH
Market value$13.70M
2.29%
Sole
1.79M
Shared
0.00
None
0.00
CVRX INC
SOLEShares1.01M
TypeSH
Market value$9.53M
1.59%
Sole
1.01M
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares1.53M
TypeSH
Market value$7.10M
1.18%
Sole
1.53M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares3.15M
TypeSH
Market value$6.65M
1.11%
Sole
3.15M
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares271.46K
TypeSH
Market value$2.27M
0.38%
Sole
271.46K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 3.22M | SH | $153.21M 25.57% | 3.22M | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 18.25M | SH | $132.28M 22.08% | 18.25M | 0.00 | 0.00 |
BIONTECH SESOLE | SPONSORED ADS | 889.82K | SH | $79.09M 13.20% | 889.82K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 8.55M | SH | $76.62M 12.79% | 8.55M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 1.33M | SH | $44.43M 7.41% | 1.33M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCSOLE | COM NEW | 1.51M | SH | $30.34M 5.06% | 1.51M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 340.43K | SH | $22.44M 3.74% | 340.43K | 0.00 | 0.00 |
SPERO THERAPEUTICS INCSOLE | COM | 9.19M | SH | $21.51M 3.59% | 9.19M | 0.00 | 0.00 |
FULCRUM THERAPEUTICS INCSOLE | COM | 1.79M | SH | $13.70M 2.29% | 1.79M | 0.00 | 0.00 |
CVRX INCSOLE | COM | 1.01M | SH | $9.53M 1.59% | 1.01M | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 1.53M | SH | $7.10M 1.18% | 1.53M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 3.15M | SH | $6.65M 1.11% | 3.15M | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 271.46K | SH | $2.27M 0.38% | 271.46K | 0.00 | 0.00 |